E

e184

VC funding HealthTech, FinTech, and SaaS

Head of Bioengineering

Full-Time
No salary listed
Expert
PhD
Portland, OR, USA
In Person
Biology & BiotechBiomedical Engineering & Medical Devices

About the job

Requirements
  • A PhD or advanced degree in engineering, bioengineering, mechanical engineering, systems engineering, or a related field, or equivalent industry experience.
  • At least 7 years of post-graduate research or industry experience developing complex integrated engineering or medical device systems.
  • Strong expertise in systems engineering and closed-loop system design.
  • Deep knowledge of fluid mechanics and perfusion system engineering, including flow control, shear stress considerations, and long-term sterile circulation.
  • Experience designing and integrating medical or bioengineering hardware platforms.
  • Proficiency with sensor integration, embedded systems, and computer-controlled instrumentation.
  • Experience leading multidisciplinary technical teams and managing complex engineering projects from concept through implementation.
  • Ability to operate strategically and hands-on within a fast-paced startup environment.
Responsibilities
  • Define and lead development of the core technology platform, integrating fluidic, mechanical, sensing, and computational subsystems into cohesive, reliable ex utero support systems.
  • Lead engineering design of perfusion architectures, oxygenation systems, mechanical assemblies, and environmental control systems for stable long-duration biological support.
  • Apply closed-loop design principles, redundancy strategies, and failure-mode analysis to ensure robustness, safety, and continuous operation of complex biological platforms.
  • Oversee integration of biosensors, optical monitoring, embedded systems, and real-time data acquisition pipelines for adaptive environmental control and automated experimentation.
  • Build, mentor, and guide multidisciplinary engineering teams across mechanical, electrical, software, and computational domains.
  • Partner with scientific teams to convert physiological and developmental requirements into engineering specifications and data-driven design decisions.
  • Establish technical roadmaps, manage engineering milestones, and communicate progress and strategy to executive leadership.
  • Guide system design toward manufacturability, reliability, and regulatory readiness, supporting future clinical translation.
Desired Qualifications
  • Systems engineering principles and architecture.
  • Closed-loop systems and control design.
  • Failure-mode analysis and redundancy planning.
  • Fluid mechanics and pump/flow control strategies.
  • Oxygenator and gas-exchange technologies.
  • Medical device and mechanical system design.
  • Biosensors, optical monitoring, and signal filtering.
  • Real-time data acquisition and control systems.
  • Precision and sterile manufacturing environments.
  • Automation and AI-driven experimental systems.
  • Control theory and reinforcement learning concepts.
  • Biomaterials, hydrogel systems, and extracellular matrix mechanics.
  • Surface coatings and fouling prevention strategies.
  • Biocompatibility and protein adsorption dynamics.
  • Regulatory translation, including FDA medical device pathways.
  • ISO 13485 and ISO 14971 quality and risk standards.

About the company

e184 is a venture capital investor focusing on HealthTech, FinTech, and SaaS in the United States, providing capital to startups to help them grow. It uses a multi-stage VC model, investing equity across early to late stages and aiming for exits such as IPOs or acquisitions, guided by leadership that coordinates capital allocation and leverages expertise in payments, banking, crypto, and investments. The firm differentiates itself through its sector focus combined with flexible stages and a willingness to explore additional verticals, using its payments, banking, and crypto know-how to guide portfolio value. Its goal is to deliver high-growth returns for investors by funding innovative startups, supporting their scale, and exiting positions profitably, while continually seeking new opportunities across industries.

Company Size

1-10

Company Stage

N/A

Total Funding

$5.8M

Headquarters

Kentucky

Founded

2023

Get referred to e184

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • e184 posted June 2026 hiring for reproductive tech and BCI specialists, signaling active execution.
  • Paterna BioSciences cited e184 participation in its October 2024 $6 million seed round.
  • The 2026 website and job listings show continued expansion from concept into staffed labs.

What critics are saying

  • The original VC positioning conflicts with 2026 biotech operations and suggests identity drift.
  • Human reproduction and artificial womb work face severe ethics, regulatory, and hiring friction.
  • If BCI, gametogenesis, or ectogenesis fail, e184 loses its entire thesis and investor narrative.

What makes e184 unique

  • e184 now builds in vitro gametogenesis, ectogenesis, genome engineering, and non-invasive BCI.
  • Its 2026 site frames one integrated biology platform across reproduction, genetics, and cognition.
  • Portland-area labs and UK BCI work create unusually deep, physical R&D infrastructure.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • 401(k) Retirement Plan
  • Paid Vacation
  • Remote Work Options
  • Flexible Work Hours
  • Wellness Program
  • Mental Health Support
  • Conference Attendance Budget
  • Professional Development Budget
  • Stock Options
  • Equity

Company News

EIN News
Oct 28th, 2024
Paterna BioSciences Secures Seed Funding to Advance Groundbreaking Male Fertility Treatment

$6 million oversubscribed seed investment to advance pioneering in vitro spermatogenesis science, offers new hope for people struggling with infertility.